Analysis of molecular cytogenetic alteration in rhabdomyosarcoma by array comparative genomic hybridization

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Liu, Chunxia ^a,b   Li, Dongliang ^a,c   Jiang, Jinfang ^a   Hu, Jianming ^a   Zhang, Wei ^d   Chen, Yunzhao ^a   Cui, Xiaobin ^a   Qi, Yan ^a   Zou, Hong ^a   Zhang, WenJie ^a   Li, Feng ^a,b  

^a SHIHEZI UNIVERSITY   (China)

^b ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^c ANHUI MEDICAL UNIVERSITY   (China)

^d XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; UBIQUITIN PROTEIN LIGASE E3;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHROMOSOME DELETION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; COPY NUMBER VARIATION; CYTOGENETICS; DOWN REGULATION; FEMALE; GENE AMPLIFICATION; GENE CLUSTER; GENE DELETION; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENE LOSS; GENE MAPPING; GENETIC ANALYSIS; GENETIC GAIN; HUMAN; HUMAN TISSUE; MALE; MIDDLE AGED; PRESCHOOL CHILD; PROTEIN DOMAIN; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RHABDOMYOSARCOMA; SCHOOL CHILD; YOUNG ADULT; CHROMOSOME ABERRATION; CLINICAL TRIAL; GENE DOSAGE; GENETICS; HUMAN CHROMOSOME; NUCLEOTIDE SEQUENCE; PATHOLOGY; TUMOR GENE;

ADOLESCENT; ADULT; AGED; BASE SEQUENCE; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; GENE DOSAGE; GENES, NEOPLASM; HUMANS; MALE; MIDDLE AGED; RHABDOMYOSARCOMA; SEQUENCE DELETION;

EID: 84899692648     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094924     Document Type: Article

References (58)

1. Christopher D, Krisjnan U, Fredrik M (2002) World Health Organization classification of tumours. Pathology and genetics of tumours of soft tissue and bone.
2. Barr FG (2001) Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma. Oncogene 20: 5736-5746. (Pubitemid 32928111)
3. Solinas-Toldo S, Lampel S, Stilgenbauer S, Nickolenko J, Benner A, et al. (1997) Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes, chromosomes and cancer 20: 399-407. (Pubitemid 27520090)
4. Pinkel D, Segraves R, Sudar D, Clark S, Poole I, et al. (1998) High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nature genetics 20: 207-211. (Pubitemid 28455458)
5. Beroukhim R, Getz G, Nghiemphu L, Barretina J, Hsueh T, et al. (2007) Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proceedings of the National Academy of Sciences 104: 20007-20012.
6. Carro A, Rico D, Rueda OM, Díaz-Uriarte R, Pisano DG (2010) waviCGH: A web application for the analysis and visualization of genomic copy number alterations. Nucleic acids research 38: W182-W187.
7. Kallioniemi A (2008) CGH microarrays and cancer. Current opinion in biotechnology 19: 36-40.
8. Sherman BT, Tan Q, Kir J, Liu D, Bryant D, et al. (2007) DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic acids research 35: W169- W175.
9. Lu M, Zhang Q, Deng M, Miao J, Guo Y, et al. (2008) An analysis of human microRNA and disease associations. PloS one 3: e3420.
10. Cho W (2007) OncomiRs: The discovery and progress of microRNAs in cancers. Molecular cancer 6: 60.
11. Lu M, Shi B, Wang J, Cao Q, Cui Q (2010) TAM: A method for enrichment and depletion analysis of a microRNA category in a list of microRNAs. BMC bioinformatics 11: 419.
12. Smyth GK, Speed T (2003) Normalization of cDNA microarray data. Methods 31: 265-273. (Pubitemid 37338763)
13. Workman C, Jensen LJ, Jarmer H, Berka R, Gautier L, et al. (2002) A new nonlinear normalization method for reducing variability in DNA microarray experiments. Genome biol 3: 1-16.
14. Molla M (2007) Novel Uses for Machine Learning and Other Computational Methods for the Design and Interpretation of Genetic Microarrays. In PhD thesis University of Wisconsin-Madison Department of Computer Sciences.
15. Olshen AB, Venkatraman E, Lucito R, Wigler M (2004) Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 5: 557-572. (Pubitemid 41180205)
16. Shi ZZ, Liang JW, Zhan T, Wang BS, Lin DC, et al. (2011) Genomic alterations with impact on survival in esophageal squamous cell carcinoma identified by array comparative genomic hybridization. Genes, chromosomes and cancer 50: 518-526.
17. Krzywinski M, Schein J, Birol I, Connors J, Gascoyne R, et al. (2009) Circos: An information aesthetic for comparative genomics. Genome research 19: 1639- 1645.
18. Nigro JM, Misra A, Zhang L, Smirnov I, Colman H, et al. (2005) Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma. Cancer research 65: 1678-1686. (Pubitemid 40478592)
19. Tsafrir D, Bacolod M, Selvanayagam Z, Tsafrir I, Shia J, et al. (2006) Relationship of gene expression and chromosomal abnormalities in colorectal cancer. Cancer research 66: 2129-2137.
20. Hertzberg L, Betts DR, Raimondi SC, Schäfer BW, Notterman DA, et al. (2007) Prediction of chromosomal aneuploidy from gene expression data. Genes, chromosomes and cancer 46: 75-86. (Pubitemid 44772874)
21. Rodriguez-Perales S, Martiínez-Ramiírez A, de Andrés SA, Valle L, Urioste M, et al. (2004) Molecular cytogenetic characterization of rhabdomyosarcoma cell lines. Cancer genetics and cytogenetics 148: 35-43. (Pubitemid 38018878)
22. Goldstein M, Meller I, Issakov J, Orr-Urtreger A (2006) Novel genes implicated in embryonal, alveolar, and pleomorphic rhabdomyosarcoma: A cytogenetic and molecular analysis of primary tumors. Neoplasia (New York, NY) 8: 332.
23. Missiaglia E, Selfe J, Hamdi M, Williamson D, Schaaf G, et al. (2009) Genomic imbalances in rhabdomyosarcoma cell lines affect expression of genes frequently altered in primary tumors: An approach to identify candidate genes involved in tumor development. Genes, chromosomes and cancer 48: 455-467.
24. Barr FG, Duan F, Smith LM, Gustafson D, Pitts M, et al. (2009) Genomic and clinical analyses of 2p24 and 12q13-q14 amplification in alveolar rhabdomyosarcoma: A report from the Children's Oncology Group. Genes, chromosomes and cancer 48: 661-672.
25. Williamson D, Missiaglia E, de Reyniès A, Pierron G, Thuille B, et al. (2010) Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma. Journal of Clinical Oncology 28: 2151-2158.
26. Paulson V, Chandler G, Rakheja D, Galindo RL, Wilson K, et al. (2011) Highresolution array CGH identifies common mechanisms that drive embryonal rhabdomyosarcoma pathogenesis. Genes, chromosomes and cancer 50: 397- 408.
27. Tostar U, Toftgard R, Zaphiropoulos PG, Shimokawa T (2010) Reduction of human embryonal rhabdomyosarcoma tumor growth by inhibition of the hedgehog signaling pathway. Genes & cancer 1: 941-951.
28. Eichenmüller M, Hemmerlein B, Von Schweinitz D, Kappler R (2010) Betulinic acid induces apoptosis and inhibits hedgehog signalling in rhabdomyosarcoma. British journal of cancer 103: 43-51.
29. Zibat A, Missiaglia E, Rosenberger A, Pritchard-Jones K, Shipley J, et al. (2010) Activation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative alveolar rhabdomyosarcoma. Oncogene 29: 6323-6330.
30. Guo X, Stafford LJ, Bryan B, Xia C, Ma W, et al. (2003) A Rac/Cdc42-specific exchange factor, GEFT, induces cell proliferation, transformation, and migration. Journal of Biological Chemistry 278: 13207-13215. (Pubitemid 36800090)
31. Fernandez-Zapico ME, Gonzalez-Paz NC, Weiss E, Savoy DN, Molina JR, et al. (2005) Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis. Cancer cell 7: 39-49. (Pubitemid 40126381)
32. Citterio C, Menacho-Marquez M, Garcia-Escudero R, Larive RM, Barreiro O, et al. (2012) The Rho exchange factors Vav2 and Vav3 control a lung metastasis-specific transcriptional program in breast cancer cells. Science Signaling 5: ra71.
33. Lazer G, Idelchuk Y, Schapira V, Pikarsky E, Katzav S (2009) The haematopoietic specific signal transducer Vav1 is aberrantly expressed in lung cancer and plays a role in tumourigenesis. The Journal of pathology 219: 25-34.
34. Honda R, Tanaka H, Yasuda H (1997) Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS letters 420: 25-27. (Pubitemid 28037193)
35. Taylor AC, Shu L, Danks MK, Poquette CA, Shetty S, et al. (2000) P53 mutation and MDM2 amplification frequency in pediatric rhabdomyosarcoma tumors and cell lines. Medical and pediatric oncology 35: 96-103.
36. Miyachi M, Kakazu N, Yagyu S, Katsumi Y, Tsubai-Shimizu S, et al. (2009) Restoration of p53 pathway by nutlin-3 induces cell cycle arrest and apoptosis in human rhabdomyosarcoma cells. Clinical Cancer Research 15: 4077-4084.
37. Khatib ZA, Matsushime H, Valentine M, Shapiro DN, Sherr CJ, et al. (1993) Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas. Cancer research 53: 5535-5541. (Pubitemid 23342180)
38. Ferracini R, Olivero M, Di Renzo MF, Martano M, De Giovanni C, et al. (1996) Retrogenic expression of the MET proto-oncogene correlates with the invasive phenotype of human rhabdomyosarcomas. Oncogene 12: 1697.
39. Libura J, Drukala J, Majka M, Tomescu O, Navenot JM, et al. (2002) CXCR4- SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion Presented at the Annual Meeting of the American Society of Hematology, Orlando, FL, December 7-11, 2001. Blood 100: 2597- 2606.
40. Sharp R, Recio JA, Jhappan C, Otsuka T, Liu S, et al. (2002) Synergism between INK4a/ARF inactivation and aberrant HGF/SF signaling in rhabdomyosarcomagenesis. Nature medicine 8: 1276-1280. (Pubitemid 35373560)
41. Taulli R, Scuoppo C, Bersani F, Accornero P, Forni PE, et al. (2006) Validation of met as a therapeutic target in alveolar and embryonal rhabdomyosarcoma. Cancer research 66: 4742-4749.
42. Diomedi-Camassei F, McDowell HP, De Ioris MA, Uccini S, Altavista P, et al. (2008) Clinical significance of CXC chemokine receptor-4 and c-Met in childhood rhabdomyosarcoma. Clinical Cancer Research 14: 4119-4127.
43. Hou J, Dong J, Sun L, Geng L, Wang J, et al. (2011) Inhibition of phosphorylated c-Met in rhabdomyosarcoma cell lines by a small molecule inhibitor SU11274. J Transl Med 9: 64.
44. Chiappetta G, Ferraro A, Vuttariello E, Monaco M, Galdiero F, et al. (2008) HMGA2 mRNA expression correlates with the malignant phenotype in human thyroid neoplasias. European journal of cancer 44: 1015-1021.
45. Hristov AC, Cope L, Reyes MD, Singh M, Iacobuzio-Donahue C, et al. (2008) HMGA2 protein expression correlates with lymph node metastasis and increased tumor grade in pancreatic ductal adenocarcinoma. Modern Pathology 22: 43-49.
46. Sarhadi V, Wikman H, Salmenkivi K, Kuosma E, Sioris T, et al. (2006) Increased expression of high mobility group A proteins in lung cancer. The Journal of pathology 209: 206-212. (Pubitemid 43805416)
47. Wang X, Liu X, Li AY-J, Chen L, Lai L, et al. (2011) Overexpression of HMGA2 promotes metastasis and impacts survival of colorectal cancers. Clinical Cancer Research 17: 2570-2580.
48. LI Y, FAN Q-h, SONG G-x, PENG T (2011) Expression and clinical significance of HMGA1 and HMGA2 in rhabdomyosarcoma. Chinese Journal of Clinical and Experimental Pathology 6: 019.
49. Li Z, Zhang Y, Ramanujan K, Ma Y, Kirsch DG, et al. (2013) Oncogenic NRAS, Required for Pathogenesis of Embryonic Rhabdomyosarcoma, Relies upon the HMGA2 -IGF2BP2 Pathway. Cancer Res. 73(10):3041-3050.
50. Kang JU, Koo SH, Kwon KC, Park JW (2010) AMY2A: A possible tumorsuppressor gene of 1p21. 1 loss in gastric carcinoma. International journal of oncology 36: 1429.
51. Raish M, Khurshid M, Ansari MA, Chaturvedi PK, Bae S-M, et al. (2012) Analysis of molecular cytogenetic alterations in uterine leiomyosarcoma by array-based comparative genomic hybridization. Journal of cancer research and clinical oncology 138: 1173-1186.
52. Esquela-Kerscher A, Slack FJ (2006) Oncomirs-microRNAs with a role in cancer. Nature Reviews Cancer 6: 259-269.
53. Chivukula RR, Mendell JT (2008) Circular reasoning: microRNAs and cellcycle control. Trends in biochemical sciences 33: 474-481.
54. Yan D, Dong XDE, Chen X, Wang L, Lu C, et al. (2009) MicroRNA-1/206 targets c-Met and inhibits rhabdomyosarcoma development. Journal of Biological Chemistry 284: 29596-29604.
55. Wang Q, Huang Z, Xue H, Jin C, Ju X-L, et al. (2008) MicroRNA miR-24 inhibits erythropoiesis by targeting activin type I receptor ALK4. Blood 111: 588-595.
56. Kiriakidou M, Nelson PT, Kouranov A, Fitziev P, Bouyioukos C, et al. (2004) A combined computational-experimental approach predicts human microRNA targets. Genes & development 18: 1165-1178. (Pubitemid 38669037)
57. Lal A, Kim HH, Abdelmohsen K, Kuwano Y, Pullmann Jr R, et al. (2008) p16INK4a translation suppressed by miR-24. PloS one 3: e1864.
58. Berggren P, Kumar R, Sakano S, Hemminki L, Wada T, et al. (2003) Detecting homozygous deletions in the CDKN2A (p16INK4a)/ARF (p14ARF) gene in urinary bladder cancer using real-time quantitative PCR. Clinical Cancer Research 9: 235-242. (Pubitemid 36109739)